Pulmonary diagnostic tests are a series of tests which evaluate how well the lungs are performing. These tests may be performed to help diagnose disease, monitor disease progression or therapeutic ...

Asthma and COPD are defined as different disease entities, but in practice patients often show features of both diseases making it challenging for primary care clinicians to establish a correct ...

Chronic obstructive pulmonary disease (COPD) has become a global public health challenge due to its high prevalence and related mortality 1. According to the 2013 Global Burden of Disease (GBD 2013) ...

Artificial intelligence could improve the interpretation of lung function tests for the diagnosis of long-term lung diseases, according to the findings of a new study. Artificial intelligence could ...

Researchers at National Jewish Health and dozens of leading institutions around the nation have proposed new criteria for diagnosing chronic obstructive pulmonary disease (COPD), the fourth leading ...

The pattern of chronic obstructive pulmonary disease (COPD), which is commonly believed to affect only smokers, is changing.

Out of 109 participants, 48 received early treatment, accounting for 44% of the trial population.

Checking blood levels of several oxygen‐sensing molecules may be a useful noninvasive tool for diagnosis of pulmonary arterial hypertension.

Diffuse parenchymal lung diseases encompass a large number of conditions, with a wide range of causes, clinical manifestations, and imaging and pathological features, as well as variable outcomes.

DENVER, May 16, 2011 /PRNewswire/ -- VIDA Diagnostics, a leading developer of quantitative pulmonary imaging software, announced today the launch of its new Apollo™ Software for the evaluation of ...

ICS-containing inhalers are commonly prescribed to patients after acute respiratory tract infections, often without diagnostic evaluation.

Elastokines can serve as biomarkers of matrix turnover and are associated with clinical outcomes in patients with IPF.